Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
申请人:——
公开号:US20020103203A1
公开(公告)日:2002-08-01
Amide compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
Miceller-Mediated Phosphomolybdic Acid: Highly Effective Reusable Catalyst for Synthesis of Quinoline and Its Derivatives
作者:Atul Chaskar、Vikas Padalkar、Kiran Phatangare、Bhushan Langi、Chetan Shah
DOI:10.1080/00397910903245141
日期:2010.7.12
A simple, efficient, and ecofriendly procedure has been developed for the synthesis of quinoline and its derivatives in a one-pot reaction of aniline with crotonaldehyde or methyl vinyl ketone using phosphomolybdic acid as solid acid catalyst in miceller media. The catalyst was easily recycled and reused.